APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Albumin Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Human Albumin Injection Market Outlook and Growth Opportunities 2026

22 December 2025195 pages

Choose your research edition.

Industry ResearchHuman Albumin Injection Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Albumin Injection Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Human Albumin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Albumin Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Albumin Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Human Albumin Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Human Albumin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Albumin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Albumin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Human Albumin Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Human Albumin Injection market include Takeda, Nanyue Biopharmaceuticals, Grifols, Hualan Bio, Baxter, SK Plasma, Octapharma, Kedrion Biopharma, Inc. and Instituto Grifols, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Albumin Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Albumin Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Albumin Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Albumin Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Albumin Injection Segment by Company

Takeda

Nanyue Biopharmaceuticals

Grifols

Hualan Bio

Baxter

SK Plasma

Octapharma

Kedrion Biopharma, Inc.

Instituto Grifols

Green Cross

GE HealthCare

CSL Behring

Biotest (UK) Ltd

Bio Products Laboratory

Human Albumin Injection Segment by Type

Blood Extraction

Recombine

Human Albumin Injection Segment by Application

Hospital

Clinic

Human Albumin Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Human Albumin Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Human Albumin Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Human Albumin Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Human Albumin Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Albumin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Albumin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Albumin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Albumin Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Albumin Injection industry.

Chapter 3: Detailed analysis of Human Albumin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Human Albumin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Human Albumin Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Human Albumin Injection Industry Trends Table 2. Human Albumin Injection Industry Drivers Table 3. Human Albumin Injection Industry Opportunities and Challenges Table 4. Human Albumin Injection Industry Restraints Table 5. Global Human Albumin Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Human Albumin Injection Revenue Share by Company (2021-2026) Table 7. Global Human Albumin Injection Sales Volume by Company (k units) & (2021-2026) Table 8. Global Human Albumin Injection Sales Volume Share by Company (2021-2026) Table 9. Global Human Albumin Injection Average Price (US$/unit) of Company (2021-2026) Table 10. Global Human Albumin Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Human Albumin Injection Key Company Manufacturing Base & Headquarters Table 12. Global Human Albumin Injection Company, Product Type & Application Table 13. Global Human Albumin Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Albumin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Blood Extraction Table 18. Significant Companies of Recombine Table 19. Global Human Albumin Injection Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Human Albumin Injection Sales Volume by Type (2021-2026) & (k units) Table 21. Global Human Albumin Injection Sales Volume by Type (2027-2032) & (k units) Table 22. Global Human Albumin Injection Sales Volume Share by Type (2021-2026) Table 23. Global Human Albumin Injection Sales Volume Share by Type (2027-2032) Table 24. Global Human Albumin Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Human Albumin Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Human Albumin Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Human Albumin Injection Sales Value Share by Type (2021-2026) Table 28. Global Human Albumin Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Global Human Albumin Injection Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Human Albumin Injection Sales Volume by Application (2021-2026) & (k units) Table 33. Global Human Albumin Injection Sales Volume by Application (2027-2032) & (k units) Table 34. Global Human Albumin Injection Sales Volume Share by Application (2021-2026) Table 35. Global Human Albumin Injection Sales Volume Share by Application (2027-2032) Table 36. Global Human Albumin Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Human Albumin Injection Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Human Albumin Injection Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Human Albumin Injection Sales Value Share by Application (2021-2026) Table 40. Global Human Albumin Injection Sales Value Share by Application (2027-2032) Table 41. Global Human Albumin Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Human Albumin Injection Sales by Region (2021-2026) & (k units) Table 43. Global Human Albumin Injection Sales Market Share by Region (2021-2026) Table 44. Global Human Albumin Injection Sales by Region (2027-2032) & (k units) Table 45. Global Human Albumin Injection Sales Market Share by Region (2027-2032) Table 46. Global Human Albumin Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Human Albumin Injection Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Human Albumin Injection Sales Value Share by Region (2021-2026) Table 49. Global Human Albumin Injection Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Human Albumin Injection Sales Value Share by Region (2027-2032) Table 51. Global Human Albumin Injection Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Human Albumin Injection Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Human Albumin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Human Albumin Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Human Albumin Injection Sales by Country (2021-2026) & (k units) Table 56. Global Human Albumin Injection Sales Market Share by Country (2021-2026) Table 57. Global Human Albumin Injection Sales by Country (2027-2032) & (k units) Table 58. Global Human Albumin Injection Sales Market Share by Country (2027-2032) Table 59. Global Human Albumin Injection Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Human Albumin Injection Sales Value Market Share by Country (2021-2026) Table 61. Global Human Albumin Injection Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Human Albumin Injection Sales Value Market Share by Country (2027-2032) Table 63. Takeda Company Information Table 64. Takeda Business Overview Table 65. Takeda Human Albumin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Takeda Human Albumin Injection Product Portfolio Table 67. Takeda Recent Development Table 68. Nanyue Biopharmaceuticals Company Information Table 69. Nanyue Biopharmaceuticals Business Overview Table 70. Nanyue Biopharmaceuticals Human Albumin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolio Table 72. Nanyue Biopharmaceuticals Recent Development Table 73. Grifols Company Information Table 74. Grifols Business Overview Table 75. Grifols Human Albumin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Grifols Human Albumin Injection Product Portfolio Table 77. Grifols Recent Development Table 78. Hualan Bio Company Information Table 79. Hualan Bio Business Overview Table 80. Hualan Bio Human Albumin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Hualan Bio Human Albumin Injection Product Portfolio Table 82. Hualan Bio Recent Development Table 83. Baxter Company Information Table 84. Baxter Business Overview Table 85. Baxter Human Albumin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Baxter Human Albumin Injection Product Portfolio Table 87. Baxter Recent Development Table 88. SK Plasma Company Information Table 89. SK Plasma Business Overview Table 90. SK Plasma Human Albumin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. SK Plasma Human Albumin Injection Product Portfolio Table 92. SK Plasma Recent Development Table 93. Octapharma Company Information Table 94. Octapharma Business Overview Table 95. Octapharma Human Albumin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Octapharma Human Albumin Injection Product Portfolio Table 97. Octapharma Recent Development Table 98. Kedrion Biopharma, Inc. Company Information Table 99. Kedrion Biopharma, Inc. Business Overview Table 100. Kedrion Biopharma, Inc. Human Albumin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolio Table 102. Kedrion Biopharma, Inc. Recent Development Table 103. Instituto Grifols Company Information Table 104. Instituto Grifols Business Overview Table 105. Instituto Grifols Human Albumin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Instituto Grifols Human Albumin Injection Product Portfolio Table 107. Instituto Grifols Recent Development Table 108. Green Cross Company Information Table 109. Green Cross Business Overview Table 110. Green Cross Human Albumin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Green Cross Human Albumin Injection Product Portfolio Table 112. Green Cross Recent Development Table 113. GE HealthCare Company Information Table 114. GE HealthCare Business Overview Table 115. GE HealthCare Human Albumin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. GE HealthCare Human Albumin Injection Product Portfolio Table 117. GE HealthCare Recent Development Table 118. CSL Behring Company Information Table 119. CSL Behring Business Overview Table 120. CSL Behring Human Albumin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. CSL Behring Human Albumin Injection Product Portfolio Table 122. CSL Behring Recent Development Table 123. Biotest (UK) Ltd Company Information Table 124. Biotest (UK) Ltd Business Overview Table 125. Biotest (UK) Ltd Human Albumin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Biotest (UK) Ltd Human Albumin Injection Product Portfolio Table 127. Biotest (UK) Ltd Recent Development Table 128. Bio Products Laboratory Company Information Table 129. Bio Products Laboratory Business Overview Table 130. Bio Products Laboratory Human Albumin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Bio Products Laboratory Human Albumin Injection Product Portfolio Table 132. Bio Products Laboratory Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Human Albumin Injection Distributors List Table 136. Human Albumin Injection Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Human Albumin Injection Product Image Figure 2. Global Human Albumin Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Albumin Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Human Albumin Injection Sales (2021-2032) & (k units) Figure 5. Global Human Albumin Injection Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Human Albumin Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Blood Extraction Image Figure 10. Recombine Image Figure 11. Global Human Albumin Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Human Albumin Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Human Albumin Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Human Albumin Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Human Albumin Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Human Albumin Injection Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Human Albumin Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Human Albumin Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Human Albumin Injection Sales Volume Share by Application (2021-2032) Figure 22. Global Human Albumin Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Human Albumin Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Human Albumin Injection Sales Value Share by Application (2021-2032) Figure 25. Global Human Albumin Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Human Albumin Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Human Albumin Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Human Albumin Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Human Albumin Injection Sales Value (2021-2032) & (US$ Million) Figure 30. North America Human Albumin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Human Albumin Injection Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Human Albumin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Human Albumin Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Human Albumin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Human Albumin Injection Sales Value (2021-2032) & (US$ Million) Figure 36. South America Human Albumin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Human Albumin Injection Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Human Albumin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Human Albumin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Human Albumin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Human Albumin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Human Albumin Injection Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Human Albumin Injection Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Extraction
  • Recombine
Applications
  • Hospital
  • Clinic
Companies covered
  • Takeda
  • Nanyue Biopharmaceuticals
  • Grifols
  • Hualan Bio
  • Baxter
  • SK Plasma
  • Octapharma
  • Kedrion Biopharma, Inc.
  • Instituto Grifols
  • Green Cross
  • GE HealthCare
  • CSL Behring
  • Biotest (UK) Ltd
  • Bio Products Laboratory

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Albumin Injection Sales Value (2021-2032)
  4. 1.2.2 Global Human Albumin Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Human Albumin Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Human Albumin Injection Market Dynamics
  1. 2.1 Human Albumin Injection Industry Trends
  2. 2.2 Human Albumin Injection Industry Drivers
  3. 2.3 Human Albumin Injection Industry Opportunities and Challenges
  4. 2.4 Human Albumin Injection Industry Restraints
3 Human Albumin Injection Market by Company
  1. 3.1 Global Human Albumin Injection Company Revenue Ranking in 2025
  2. 3.2 Global Human Albumin Injection Revenue by Company (2021-2026)
  3. 3.3 Global Human Albumin Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Human Albumin Injection Average Price by Company (2021-2026)
  5. 3.5 Global Human Albumin Injection Company Ranking (2024-2026)
  6. 3.6 Global Human Albumin Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Human Albumin Injection Company Product Type and Application
  8. 3.8 Global Human Albumin Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Human Albumin Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Human Albumin Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Human Albumin Injection Market by Type
  1. 4.1 Human Albumin Injection Type Introduction
  2. 4.1.1 Blood Extraction
  3. 4.1.2 Recombine
  4. 4.2 Global Human Albumin Injection Sales Volume by Type
  5. 4.2.1 Global Human Albumin Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Human Albumin Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Human Albumin Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Human Albumin Injection Sales Value by Type
  9. 4.3.1 Global Human Albumin Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Human Albumin Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Human Albumin Injection Sales Value Share by Type (2021-2032)
5 Human Albumin Injection Market by Application
  1. 5.1 Human Albumin Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Human Albumin Injection Sales Volume by Application
  5. 5.2.1 Global Human Albumin Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Human Albumin Injection Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Human Albumin Injection Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Human Albumin Injection Sales Value by Application
  9. 5.3.1 Global Human Albumin Injection Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Human Albumin Injection Sales Value by Application (2021-2032)
  11. 5.3.3 Global Human Albumin Injection Sales Value Share by Application (2021-2032)
6 Human Albumin Injection Regional Sales and Value Analysis
  1. 6.1 Global Human Albumin Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Albumin Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Human Albumin Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Human Albumin Injection Sales by Region (2027-2032)
  5. 6.3 Global Human Albumin Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Human Albumin Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Human Albumin Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Human Albumin Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Human Albumin Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Human Albumin Injection Sales Value (2021-2032)
  12. 6.6.2 North America Human Albumin Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Human Albumin Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Human Albumin Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Human Albumin Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Human Albumin Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Human Albumin Injection Sales Value (2021-2032)
  21. 6.9.2 South America Human Albumin Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Human Albumin Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Human Albumin Injection Sales Value Share by Country, 2025 VS 2032
7 Human Albumin Injection Country-level Sales and Value Analysis
  1. 7.1 Global Human Albumin Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Human Albumin Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Human Albumin Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Human Albumin Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Human Albumin Injection Sales by Country (2027-2032)
  6. 7.4 Global Human Albumin Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Human Albumin Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Human Albumin Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Human Albumin Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Human Albumin Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Human Albumin Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Human Albumin Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Human Albumin Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Human Albumin Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Human Albumin Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Human Albumin Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Human Albumin Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Human Albumin Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Human Albumin Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Human Albumin Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Human Albumin Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Human Albumin Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Human Albumin Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Human Albumin Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Human Albumin Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Human Albumin Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Human Albumin Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Human Albumin Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Human Albumin Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Human Albumin Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Human Albumin Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Human Albumin Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Human Albumin Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Human Albumin Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Human Albumin Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Human Albumin Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Human Albumin Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Human Albumin Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Human Albumin Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Human Albumin Injection Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Nanyue Biopharmaceuticals
  8. 8.2.1 Nanyue Biopharmaceuticals Company Information
  9. 8.2.2 Nanyue Biopharmaceuticals Business Overview
  10. 8.2.3 Nanyue Biopharmaceuticals Human Albumin Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolio
  12. 8.2.5 Nanyue Biopharmaceuticals Recent Developments
  13. 8.3 Grifols
  14. 8.3.1 Grifols Company Information
  15. 8.3.2 Grifols Business Overview
  16. 8.3.3 Grifols Human Albumin Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Grifols Human Albumin Injection Product Portfolio
  18. 8.3.5 Grifols Recent Developments
  19. 8.4 Hualan Bio
  20. 8.4.1 Hualan Bio Company Information
  21. 8.4.2 Hualan Bio Business Overview
  22. 8.4.3 Hualan Bio Human Albumin Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hualan Bio Human Albumin Injection Product Portfolio
  24. 8.4.5 Hualan Bio Recent Developments
  25. 8.5 Baxter
  26. 8.5.1 Baxter Company Information
  27. 8.5.2 Baxter Business Overview
  28. 8.5.3 Baxter Human Albumin Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Baxter Human Albumin Injection Product Portfolio
  30. 8.5.5 Baxter Recent Developments
  31. 8.6 SK Plasma
  32. 8.6.1 SK Plasma Company Information
  33. 8.6.2 SK Plasma Business Overview
  34. 8.6.3 SK Plasma Human Albumin Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 SK Plasma Human Albumin Injection Product Portfolio
  36. 8.6.5 SK Plasma Recent Developments
  37. 8.7 Octapharma
  38. 8.7.1 Octapharma Company Information
  39. 8.7.2 Octapharma Business Overview
  40. 8.7.3 Octapharma Human Albumin Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Octapharma Human Albumin Injection Product Portfolio
  42. 8.7.5 Octapharma Recent Developments
  43. 8.8 Kedrion Biopharma, Inc.
  44. 8.8.1 Kedrion Biopharma, Inc. Company Information
  45. 8.8.2 Kedrion Biopharma, Inc. Business Overview
  46. 8.8.3 Kedrion Biopharma, Inc. Human Albumin Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolio
  48. 8.8.5 Kedrion Biopharma, Inc. Recent Developments
  49. 8.9 Instituto Grifols
  50. 8.9.1 Instituto Grifols Company Information
  51. 8.9.2 Instituto Grifols Business Overview
  52. 8.9.3 Instituto Grifols Human Albumin Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Instituto Grifols Human Albumin Injection Product Portfolio
  54. 8.9.5 Instituto Grifols Recent Developments
  55. 8.10 Green Cross
  56. 8.10.1 Green Cross Company Information
  57. 8.10.2 Green Cross Business Overview
  58. 8.10.3 Green Cross Human Albumin Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Green Cross Human Albumin Injection Product Portfolio
  60. 8.10.5 Green Cross Recent Developments
  61. 8.11 GE HealthCare
  62. 8.11.1 GE HealthCare Company Information
  63. 8.11.2 GE HealthCare Business Overview
  64. 8.11.3 GE HealthCare Human Albumin Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 GE HealthCare Human Albumin Injection Product Portfolio
  66. 8.11.5 GE HealthCare Recent Developments
  67. 8.12 CSL Behring
  68. 8.12.1 CSL Behring Company Information
  69. 8.12.2 CSL Behring Business Overview
  70. 8.12.3 CSL Behring Human Albumin Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 CSL Behring Human Albumin Injection Product Portfolio
  72. 8.12.5 CSL Behring Recent Developments
  73. 8.13 Biotest (UK) Ltd
  74. 8.13.1 Biotest (UK) Ltd Company Information
  75. 8.13.2 Biotest (UK) Ltd Business Overview
  76. 8.13.3 Biotest (UK) Ltd Human Albumin Injection Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Biotest (UK) Ltd Human Albumin Injection Product Portfolio
  78. 8.13.5 Biotest (UK) Ltd Recent Developments
  79. 8.14 Bio Products Laboratory
  80. 8.14.1 Bio Products Laboratory Company Information
  81. 8.14.2 Bio Products Laboratory Business Overview
  82. 8.14.3 Bio Products Laboratory Human Albumin Injection Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bio Products Laboratory Human Albumin Injection Product Portfolio
  84. 8.14.5 Bio Products Laboratory Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Albumin Injection Value Chain Analysis
  2. 9.1.1 Human Albumin Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Albumin Injection Sales Mode & Process
  6. 9.2 Human Albumin Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Albumin Injection Distributors
  9. 9.2.3 Human Albumin Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst